• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在模拟体液中合成的羟基磷灰石-壳聚糖生物复合材料及其载药研究。

Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies.

机构信息

Chemical Engineering Department, Istanbul Technical University, ITU Ayazaga Kampusu, Maslak, Istanbul, 34469, Turkey.

出版信息

J Mater Sci Mater Med. 2017 Oct 6;28(11):180. doi: 10.1007/s10856-017-5961-0.

DOI:10.1007/s10856-017-5961-0
PMID:28986683
Abstract

Hydroxyapatite (HAp) is a bioceramic applied in the biomedical areas, such as matrices for drug release control. Chitosan (CTS), a natural polymer, is another material has been widely investigated for its potential use in the drug delivery systems. In this study, the composites of HAp-CTS are produced in order to investigate their drug loading and release studies. First of all, HAp-CTS composites are produced in the presence of simulated body fluid (SBF). Analysis confirmed the structure of HAp-CTS composites. Secondly, composites are encapsulated with 5-Fluorouracil (5-FU). The weight ratio of CTS is varied to realize its effect on drug loading of 5-Fluorouracil, a cancer drug, for the ratios of 1:1, 1:2 and 1:4 of HAp-CTS. The weight ratio giving the greatest drug load efficiency is selected for the last step of the study. Crosslinking agent, glutaraldehyde, are changed from 0 to 5% on the selected sample, then, drug loading is examined again in various environment owing different pH. Furthermore, drug release studies are conducted. To understand the structure and morphology of the samples, XRD, FTIR, SEM and Uv-Spectrum are applied. It is observed that weight ratio of polymer and crosslinking agent can be manipulated to adjust drug loading. Release kinetics are shown the Fickian diffusion. This new produced material can be applicable for drug delivery.

摘要

羟基磷灰石(HAp)是一种应用于生物医学领域的生物陶瓷,例如药物释放控制的基质。壳聚糖(CTS)是一种天然聚合物,因其在药物传递系统中的潜在应用而受到广泛研究。在这项研究中,制备了 HAp-CTS 复合材料,以研究其药物负载和释放研究。首先,在模拟体液(SBF)存在下制备了 HAp-CTS 复合材料。分析证实了 HAp-CTS 复合材料的结构。其次,用 5-氟尿嘧啶(5-FU)包封复合材料。改变 CTS 的重量比,以实现其对癌症药物 5-氟尿嘧啶的药物负载的影响,HAp-CTS 的比例为 1:1、1:2 和 1:4。选择在所选样品中添加 0 至 5%的交联剂戊二醛,以获得最大药物负载效率的重量比,然后在不同 pH 值的各种环境中再次检查药物负载。此外,进行了药物释放研究。为了了解样品的结构和形态,应用了 XRD、FTIR、SEM 和 Uv 光谱。可以观察到可以操纵聚合物和交联剂的重量比来调节药物负载。释放动力学表现为菲克扩散。这种新生产的材料可适用于药物传递。

相似文献

1
Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies.在模拟体液中合成的羟基磷灰石-壳聚糖生物复合材料及其载药研究。
J Mater Sci Mater Med. 2017 Oct 6;28(11):180. doi: 10.1007/s10856-017-5961-0.
2
pH responsive N-succinyl chitosan/Poly (acrylamide-co-acrylic acid) hydrogels and in vitro release of 5-fluorouracil.pH响应性N-琥珀酰壳聚糖/聚(丙烯酰胺-共-丙烯酸)水凝胶及5-氟尿嘧啶的体外释放
PLoS One. 2017 Jul 5;12(7):e0179250. doi: 10.1371/journal.pone.0179250. eCollection 2017.
3
Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.载5-氟尿嘧啶壳聚糖纳米粒的制剂、表征及体外释放研究
Int J Biol Macromol. 2020 Aug 1;156:783-791. doi: 10.1016/j.ijbiomac.2020.04.112. Epub 2020 Apr 19.
4
The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites.载双羟萘酸肺癌抑制剂的纳米羟基磷灰石-壳聚糖-PLGA 复合材料的细胞选择性毒性。
Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:371-377. doi: 10.1016/j.msec.2018.04.028. Epub 2018 Apr 14.
5
Agarose encapsulated mesoporous carbonated hydroxyapatite nanocomposites powder for drug delivery.用于药物递送的琼脂糖包裹介孔碳酸羟基磷灰石纳米复合材料粉末
J Photochem Photobiol B. 2017 Jan;166:220-231. doi: 10.1016/j.jphotobiol.2016.12.005. Epub 2016 Dec 21.
6
Organically modified clay supported chitosan/hydroxyapatite-zinc oxide nanocomposites with enhanced mechanical and biological properties for the application in bone tissue engineering.有机改性黏土负载壳聚糖/羟基磷灰石-氧化锌纳米复合材料,具有增强的机械和生物学性能,可应用于骨组织工程。
Int J Biol Macromol. 2018 Jan;106:11-19. doi: 10.1016/j.ijbiomac.2017.07.168. Epub 2017 Jul 31.
7
Research on 5-fluorouracil as a drug carrier materials with its in vitro release properties on organic modified magadiite.研究 5-氟尿嘧啶作为药物载体材料及其在有机改性镁铝水滑石上的体外释放性能。
Eur J Pharm Sci. 2019 Mar 15;130:44-53. doi: 10.1016/j.ejps.2019.01.017. Epub 2019 Jan 17.
8
Chitosan/beidellite nanocomposite as diclofenac carrier.壳聚糖/膨润土纳米复合材料作为双氯芬酸载体。
Int J Biol Macromol. 2019 Apr 1;126:44-53. doi: 10.1016/j.ijbiomac.2018.12.205. Epub 2018 Dec 23.
9
Electrospun biomimetic nanocomposite nanofibers of hydroxyapatite/chitosan for bone tissue engineering.用于骨组织工程的羟基磷灰石/壳聚糖电纺仿生纳米复合纳米纤维
Biomaterials. 2008 Nov;29(32):4314-22. doi: 10.1016/j.biomaterials.2008.07.038. Epub 2008 Aug 20.
10
Synthesis and characterization of carboxymethyl chitosan/FeO and MnFeO nanocomposites hydrogels for loading and release of curcumin.载姜黄素羧甲基壳聚糖/FeO 和 MnFeO 纳米复合材料水凝胶的合成与表征。
J Photochem Photobiol B. 2018 Aug;185:206-214. doi: 10.1016/j.jphotobiol.2018.06.014. Epub 2018 Jun 23.

引用本文的文献

1
5-Fluorouracil adsorption on graphene oxide-amine modified graphene oxide/hydroxyapatite composite for drug delivery applications: Optimization and release kinetics studies.用于药物递送应用的5-氟尿嘧啶在氧化石墨烯-胺修饰的氧化石墨烯/羟基磷灰石复合材料上的吸附:优化与释放动力学研究
Heliyon. 2024 Sep 28;10(19):e38494. doi: 10.1016/j.heliyon.2024.e38494. eCollection 2024 Oct 15.
2
Modified five times simulated body fluid for efficient biomimetic mineralization.经过五次改性的模拟体液用于高效仿生矿化。
Heliyon. 2024 Jun 12;10(12):e32850. doi: 10.1016/j.heliyon.2024.e32850. eCollection 2024 Jun 30.
3
Enhanced Osteogenesis of Dental Pulp Stem Cells In Vitro Induced by Chitosan-PEG-Incorporated Calcium Phosphate Cement.

本文引用的文献

1
[Fabrication and evaluation of hydroxyapatite-chitosan scaffold via simulated body fluid biomimetic mineralization].通过模拟体液仿生矿化制备及评价羟基磷灰石-壳聚糖支架
Hua Xi Kou Qiang Yi Xue Za Zhi. 2016 Feb;34(1):6-11. doi: 10.7518/hxkq.2016.01.002.
2
Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer.用于治疗结直肠癌的5-氟尿嘧啶肠溶纳米颗粒的制备与表征,以实现持续和局部释放
Saudi Pharm J. 2015 Jul;23(3):308-14. doi: 10.1016/j.jsps.2014.11.010. Epub 2014 Dec 11.
3
Development of lattice-inserted 5-Fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system.
壳聚糖-聚乙二醇复合磷酸钙骨水泥体外诱导牙髓干细胞成骨增强
Polymers (Basel). 2021 Jul 9;13(14):2252. doi: 10.3390/polym13142252.
4
An Elastic Mineralized 3D Electrospun PCL Nanofibrous Scaffold for Drug Release and Bone Tissue Engineering.一种用于药物释放和骨组织工程的弹性矿化 3D 静电纺丝 PCL 纳米纤维支架。
ACS Appl Bio Mater. 2021 Apr 19;4(4):3639-3648. doi: 10.1021/acsabm.1c00134. Epub 2021 Mar 23.
作为一种化疗给药系统的晶格插入5-氟尿嘧啶-羟基磷灰石纳米颗粒的研发。
J Biomater Appl. 2015 Oct;30(4):388-97. doi: 10.1177/0885328215588307. Epub 2015 Jun 10.
4
Synthesis of hydroxyapatite crystals using carboxymethyl inulin for use as a delivery of ibuprofen.使用羧甲基菊粉合成羟基磷灰石晶体以用作布洛芬的递送载体。
Mater Sci Eng C Mater Biol Appl. 2013 Jan 1;33(1):482-9. doi: 10.1016/j.msec.2012.09.018. Epub 2012 Sep 29.
5
Preparation of chitosan-TPP microspheres as resveratrol carriers.壳聚糖-三聚磷酸钠微球作为白藜芦醇载体的制备
J Food Sci. 2014 Apr;79(4):E568-76. doi: 10.1111/1750-3841.12395. Epub 2014 Mar 12.
6
Synthesis, characterization, and antibacterial activity of cross-linked chitosan-glutaraldehyde.交联壳聚糖-戊二醛的合成、表征及抗菌活性。
Mar Drugs. 2013 May 13;11(5):1534-52. doi: 10.3390/md11051534.
7
The promotion of bone regeneration by nanofibrous hydroxyapatite/chitosan scaffolds by effects on integrin-BMP/Smad signaling pathway in BMSCs.纳米纤维羟基磷灰石/壳聚糖支架通过对骨髓间充质干细胞中整合素-BMP/Smad 信号通路的影响促进骨再生。
Biomaterials. 2013 Jun;34(18):4404-17. doi: 10.1016/j.biomaterials.2013.02.048. Epub 2013 Mar 17.
8
Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.钙磷酸盐陶瓷系统在生长因子和药物输送中的应用于骨组织工程:综述。
Acta Biomater. 2012 Apr;8(4):1401-21. doi: 10.1016/j.actbio.2011.11.017. Epub 2011 Nov 20.
9
Real-time monitoring of the mechanism of poorly crystalline apatite cement conversion in the presence of chitosan, simulated body fluid and human blood.实时监测壳聚糖、模拟体液和人血存在下磷灰石水泥转化的机制。
Dalton Trans. 2010 Dec 21;39(47):11412-23. doi: 10.1039/c0dt00731e. Epub 2010 Oct 26.
10
Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.壳寡糖纳米粒包载 ATP 的持续释放。
Int J Pharm. 2010 Jun 15;392(1-2):164-9. doi: 10.1016/j.ijpharm.2010.03.050. Epub 2010 Apr 1.